The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years. However, quality concerns over antibodies are the major challenge in this market.
Immunofluorescence assays are used extensively for the detection of viral antigens, including COVID-19. As a result, the pandemic has increased the demand for immunofluorescence assay products across the globe.
These are fast and simple methods that allow researchers to visualize the effects and dynamics of viral infections. In the current global scenario, such methods represent a crucial tool in preventing and treating these pathogens.
đđđ đđ¨đŤđ đđ§đŹđ˘đ đĄđđŹ, đđŤđđ đđđ @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571
In immunofluorescence assays, imaging instruments are used to visualize and locate the fluorescently labeled antibodies in a sample. These imaging instruments are expensive as they are equipped with advanced features and functionalities.
Emerging markets such as Brazil, China, and India are expected to offer potential growth opportunities to market players in the coming years. This can primarily be attributed to the diversified healthcare markets in these countries, coupled with the high incidence of infectious and chronic disorders, increasing healthcare expenditure, and the increasing number of R&D initiatives by various organizations.
The demand for pathology services has increased significantly for clinical applications due to the increasing prevalence of chronic diseases. Histopathology technologies account for the majority of the tests performed on cancer patients.
For More Info, Get Free 10% Customization on this report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255585571
The Immunofluorescence assay market is segmented into reagents, instruments, antibodies, kits, and consumables and accessories. The kits segment accounted for the highest growth rate in the Immunofluorescence assay market in 2020. The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls, among CROs, academic institutes, and research institutes is growing, contributing to this segment's high growth rate.
The cancer accounted for the largest share of the global immunofluorescence assays market. The large share of this segment can be attributed to the increasing prevalence of cancer globally and the widespread adoption of immunofluorescence techniques for the study and diagnosis of cancer.
The immunofluorescence assays market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostics centers, and contract research organizations. The pharmaceutical & biotechnology companies accounted for the largest share of the global immunofluorescence assays market.
The study involved four major activities in estimating the current size of the immunofluorescence assay market.
Exhaustive secondary research was done to collect information on the market and its different subsegments.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571Major Market Growth Drivers: The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R spending & healthcare expenditure.
Emerging markets are expected to provide growth opportunities for players operating in the immunofluorescence assays market in the coming years.
However, quality concerns over antibodies are the major challenge in this market.Revenue Growth Analysis: [203 Pages Report] The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period.
